CORDIS · 885155 · H2020
MULTraSonicA Multiscale modeling and simulation approaches for biomedical ultrasonic applications
Coordinator: KEMIJSKI INSTITUT (SI)
Ultrasound-guided drug and gene delivery (USDG) enables controlled and spatially precise delivery of drugs and macromolecules, encapsulated in microbubbles (MBs) and submicron gas vesicles (GVs), to target areas such as cancer tumors. It is a non-invasive, high precision, low toxicity process with drastically reduced drug dosage. These advantages open doors to numerous biomedical applications, from sonothrombolysis to bloodbrain barrier opening. However, the progress and deployment of this technology is subject to extensive experimentation and heuristics. The proposal aims to develop a virtua…
About Horizon 2020 (2014–2020)
Horizon 2020 was the EU's flagship research and innovation programme for 2014–2020, with a budget of around €77 billion. It bundled FP7's strands with the EIT and the Competitiveness and Innovation Programme, introduced a stronger societal-challenge orientation, and pushed the funding logic toward closer-to-market innovation. New calls closed in 2020 but funded projects continued through 2024.
EU contribution: €2.5M awarded to the consortium. The project runs over approximately 5 years from 2021-12-01 to 2026-11-30.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from SI
see all →- InnoRenew CoE — Renewable materials and healthy environments research and innovation centre of excellence739574 · H2020 · €15.0M
- Upsurge — City-centered approach to catalyze nature-based solutions through the EU Regenerative Urban Lighthouse for pollution alleviation and regenerative development101003818 · H2020 · €9.3M
- HELIS — High energy lithium sulphur cells and batteries666221 · H2020 · €8.0M
- STREAM — Streaming flexibility to the power system101075654 · HORIZON · €7.9M
- CINDERELA — New Circular Economy Business Model for More Sustainable Urban Construction776751 · H2020 · €6.7M
- MIKELANGELO — MIcro KErneL virtualizAtioN for hiGh pErfOrmance cLOud and hpc systems645402 · H2020 · €6.0M
Other H2020 projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon 2020 through a Joint programme of the members of the EUROfusion consortium633053 · DE · €678.8M
- H2020 — COST at a turning point: A unique framework for pan-European ST cooperation as clear demonstration of European values681463 · BE · €178.2M
- HBP SGA3 — Human Brain Project Specific Grant Agreement 3945539 · BE · €150.0M
- COVID-19 VACCINES — PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19101018100 · NO · €100.0M
- UNITE4TB — ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS101007873 · NL · €92.5M
- ERA4TB — EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS853989 · ES · €89.8M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon 2020 (2014–2020) programme, under the ERC-ADG funding scheme.
- What is the EU contribution?
- The European Commission contributes €2.5M toward a total project budget of €2.5M.
- Which EU programme funds it?
- The project is funded under Horizon 2020 (2014–2020), call ERC-2019-ADG.
- Who coordinates the project?
- The project is coordinated by KEMIJSKI INSTITUT (SI).
- What is the project timeline?
- The project runs from 2021-12-01 to 2026-11-30 — approximately 5 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 885155.